object local tumor control patient survival treatment failure outcomes analyzed assess treatment efficacy NUMBER patients fractionated proton radiation therapy rt administered skull base chordomas chondrosarcomas methods march NUMBER january NUMBER total NUMBER patients evaluated treated skull base tumors NUMBER chordoma NUMBER chondrosarcoma following various surgical procedures residual tumor detected NUMBER patients NUMBER demonstrated brainstem involvement target dosages ranged NUMBER NUMBER mean NUMBER gy equivalent range follow NUMBER NUMBER months mean NUMBER months NUMBER patients NUMBER treatment failed locally resulting local control rates NUMBER NUMBER NUMBER patients chondrosarcomas NUMBER NUMBER NUMBER patients chordomas tumor volume brainstem involvement influenced control rates tumors volumes NUMBER ml remained locally controlled compared NUMBER tumors larger NUMBER ml p NUMBER NUMBER patients brainstem involvement did experience recurrence patients brainstem involvement dose reduction brainstem tolerance constraints authors achieved tumor control rate NUMBER p NUMBER patients died disease died intercurrent disease actuarial survival rates NUMBER patients chondrosarcoma NUMBER patients chordoma grade NUMBER NUMBER late toxicities observed patients NUMBER symptomatic NUMBER conclusions proton rt offers excellent chances lasting tumor control survival acceptable risks series tumors demonstrable brainstem involvement controlled patients alive surgical debulking enhanced delivery tumoricidal doses patients large tumors disease abutting crucial normal structures benefited NUMBER year high dose small medium sized